Advertisement

PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 3–3 | Cite as

13-Valent pneumococcal conjugate vaccine better value for money

Clinical study

Reference

  1. Wilson M, et al. Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada. Infectious Diseases and Therapy : 22 Jun 2018. Available from: URL: https://doi.org/10.1007/s40121-018-0206-1Google Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations